Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Economic evaluation of the SP142 versus 22C3 PD-L1 assays in the treatment of atezolizumab plus nab-paclitaxel for patients with advanced triple negative breast cancer in the Brazilian private healthcare system.

Autor: Shimabukuro Ho, Rodrigo, Mioti Sebastião, Mariana, Venezian de Carvalho, João Paulo, Neves, Tomás, Nussbaum, Micha

Publikováno v: JBES: Brazilian Journal of Health Economics / Jornal Brasileiro de Economia da Saúde; Aug2020, Vol. 12 Issue 2, p150-154, 6p

Análise de custo-efetividade do painel de sequenciamento de nova geração do DNA circulante tumoral no diagnóstico dos pacientes com câncer de pulmão de não pequenas células não escamoso metastático. (Portuguese)

Autor: de Lima Araujo, Luiz Henrique, Coudry, Renata, Seródio Baldotto, Clarissa, Mioti Sebastião, Mariana, D'Innocenzo, Marisa, Nussbaum, Micha, Shimabukuro Ho, Rodrigo

Publikováno v: JBES: Brazilian Journal of Health Economics / Jornal Brasileiro de Economia da Saúde; Dec2019, Vol. 11 Issue 3, p221-230, 10p

Diagnostic Accuracy of Next Generation Sequencing Panel using Circulating Tumor DNA in Patients with Advanced Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.

Autor: Sebastião MM; Roche Diagnostics, São Paulo, Brazil., Ho RS; Roche Diagnostics, São Paulo, Brazil., de Carvalho JPV; Roche Diagnostics LATAM, São Paulo, Brazil., Nussbaum M; Roche Diagnostics, São Paulo, Brazil.

Publikováno v: Journal of health economics and outcomes research [J Health Econ Outcomes Res] 2020 Sep 14; Vol. 7 (2), pp. 158-163. Date of Electronic Publication: 2020 Sep 14 (Print Publication: 2020).